Autoimmune phenomena are more frequent in thymic epithelial tumors (TET) than in any other human tumor. Mysthenia gravis (MG) is by far the most common autoimmune disease in thymoma patients. MG is characterized by muscle weakness due to autoantibodies against the acetylcholine receptor (AChR), and CD4 AChR-specific T cells play a pivotal role for the production of these autoantibodies. About 10% of MG patients have a thymoma and, interestingly, only such thymomas exhibit an MG association that maintains thymuslike morphological and functional features with respect to the homing and differentiation of immature T cells. Since AChR protein is not expressed in thymomas, the specificity of the autoimmunity in thymoma-associated MG is thought to be determined by nonreceptor proteins with AChR epitopes. Such proteins are overexpressed in cortical-type MG-associated thymomas, and medullary thymomas express these proteins at barely detectable levels. Aside from this quantitative difference, the pathogenesis of anti-AChR autoimmunity might be qualitatively different in these thymoma subtypes. Our findings suggest that an antigen-specific abnormal Tcell selection,by cortical-type TET may contribute to the pathogenesis of paraneoplastic MG. In contrast, an abnormal (intratumorous) activation of autoreactive T cells may be operative in medullary thymomas.
INTRODUCTION
Thymus tumors can be histologically divided into thymic epithelial tumors (TET, including thymomas and thymic carcinoms), lymphomas, thymic germ-cell tumors, and mesenchymal neoplasms . Strikingly, paraneoplastic autoim-*Corresponding author. munity is a feature only of TET (Miiller-Hermelink, 1997 ). Among TET, organotypic and nonorganotypic TET can be distinguished . Organotypic TET are benign or malignant epithelial neoplasms that retain functional properties of the normal thymus with respect to the homing and maturation of immature thymocytes (Kirchner et Marx et al., 1996ab; and Andonopoulos et al., 1991. bOut own observations. 1992; . In addition, organotypic TET are divided into medullary, mixed, predominantly cortical (organoid), and cortical thymomas and well-differentiated thymic carcinomas based on the morphological resemblance of neoplastic epithelial cells to the normal thymic epithelial-cell subtypes . The occurrence of paraneoplastic autoimmunity is restricted to organotypic TET apart from very rare exceptions (Rosai, 1996 Marx et al., 1996a) . In contrast, nonorganotypic TET (squamous cell carcinomas, lympho-epitheliomalike carcinomas, clear-cell carcinomas, mucoepidermoid carcinomas, carcinoids, small-cell carcinomas, sarcomatoid carcinomas, or papillary adenocarcinomas) resemble their nonthymic counterparts in other organs and are not associated with paraneoplastic autoimmunity. This is particularly true for myasthenia gravis (MG) ( Table I) . Only acquired neuromyotonia, which is elicited by autoantibodies against he voltage-gated potassium channel may be an exception to this rule since it was found to be associated with thymic carcinoids that are considered nonorganotypic TET . Kirchner et al., 1992. almost exclusively occur in medullary thymomas whereas MG is mainly associated with cortical-type TET (Rosai, 1996; Mtiller-Hermelink et al., 1996) .
Investigations concerning the pathogenetic links between TET and paraneoplastic autoimmunity have been hampered because of the rarity of almost all autoimmune diseases listed in Table II (Drachman, 1994 (Table III) .
It is significant for the pathogenesis of paraneoplastic MG that there is no age and gender predilection and almost no HLA association in paraneoplastic MG as opposed to the more frequent MG type that occurs in thymitis (Table III) .
Whereas MG in thymitis patients is characterized by autoimmunity almost exclusively against the AChR, paraneoplastic MG is distinguished by a range of additional autoantibodies against striated muscle antigens (actin, myosin, actinin, ryanodine receptor, and titin) and against neuronal structures (Williams et al., 1992; Aarli et al., 1990; Marx et al., 1992; Gautel et al., 1993; Mygland et al., 1994) . Finally, surgery has strikingly contrary effects on the autoimmune symptoms in MG with thymitis compared with thymoma-associated MG (Table III) To explain the unique pattern of autoimmunity against the AChR, titin, and the ryanodine receptor, (Mygland, 1997) , and against titin (Marx, 1996a b) ( Table IV) . The only exception to the rule has been paraneoplastic antineuronal autoimmunity in thymoma/MG patients Antigen Antigen FIGURE 2 Increased frequency of AChR and neurofilament reactive T cells in thymomas. Proliferation of thymocytes from normal thymuses (n 6) and mixed and cortical-type thymomas (n 10) in response to the recombinant human neurofilament fragment aa459-737 (NF-M) and various recombinant fragments and peptides of the AChR alpha subunit. Proliferation was measured by 3H-thymidine incorporation and is given as the stimulation index (SI Tumors?
It has been a major controversy whether TET elicit autoimmunity by the intratumorous stimulation of members of the normal T-cell repertoire (Sommer et al., 1990 , Willcox, 1993 or an abnormal intratumorous T-cell selection is the main pathogenetic contribution of MG-associated TET (Fig. 1) (Somnier, 1994; Nix et al., 1997; Schalke et al., 1997) (Fig. 4a) .
To investigate the biological basis of this phenomenon at a cellular level, we checked for the frequency of AChR-reactive T cells in the peripheral blood of thymoma patients at the time of surgery and 1 week later. As shown in Fig. 4b , the number of autoreactive T cells in the peripheral blood increased 1 week after surgery in thymoma patients, whereas the opposite was true in MG patients with thymitis. These findings show that MG-associated TET exert an immunosuppressive effect not only with respect to autoantibodies ( Fig. 5a ), but also against antigen-specific T cells (Fig. 4b) . As an alternative possibility, enrichment of MG-associated TET in autoaggressive T cells by T cell recirculation has been suggested (Sommer et al., 1990) . In fact, recirculation of mature T cells into nonneoplastic thymic tissue in various species is preferentially achieved by activated but much less so by naive T cells (Surh et al., 1993) . Nevertheless, we consider this an unlikely possibility to explain the high number of autoaggressive T cells in thymomas. In support of this hypothesis and using tetanus-toxin-specific T-cell proliferation as readout, we found recently that mature T cells recirculate regularly into the normal thymus (including residual thymic tissue adjacent to thymomas) but almost never into thymomas (unpublished).
Considering the high association between abnormally expressed autoantigen epitopes (Table I) In our opinion, all the features outlined so far can best be reconciled with a two-stage model, as given in Fig. 5 . According to this model, the MG-associated TET provide an increased number of autoreactive naive T cells, and on the second stage, these T cells are activated in the extratumorous "periphery." The "periphery" can be clearly the residual thymus close to the TET since we could detect a high number of antigen-specific T cells there (unpublished). However, other lymphoid organs and probably the bone marrow also have to play a role in this process, because extended thymomectomy (including the residual thymus) is not followed by a decline but by an increase of autoantibody titers instead (Fig. 4a) (Somnier, 1994; Nix et al., 1997; Schalke et al., 1997) . (b) Increased frequency of AChR and neurofilament-reactive T cells in the peripheral blood week after surgery in MG patients with mixed and cortical thymoma (n 9). The figures given indicate the percentage of positive wells detected in antigen-specific T-cell proliferation assays, combining all assays with the stimulating autoantigen fragments given in Fig. 2 . By contrast, the frequency of autoreactive T cells in patients with thymitis declines slightly after surgery.
that we (Fig. 2) and others (Sommer et al., 1990 ) have shown to recognize a broad spectrum of autoantigen epitopes (including cytoplasmic sequences). Future experiments will have to show whether further cross-reacting epitopes occur inside TET. Another apparent paradox is the finding that expression of the AChR epitope alpha 373-380 in TET is clearly associated with anti-AChR autoimmunity, but that AChR alpha 373-380 peptide-specific T cells have not been detected in MG/thymoma patients (Fig. 2) . According to the pathogenetic model suggested in Fig. 5 , we favor the view that the peptide homologues of alpha 373-380 in neoplastic epithelial cells could function as selecting peptides for immature thymocytes . In this case, one would in fact predict that mature T cells might not respond to these abnormally expressed peptides because selecting peptides in the thymus is known to be nonstimulatory or even antagonistic for mature T cells outside the thymus (Ashton-Rickardt and Tonegawa, 1994; Hogguist et al., 1994) . This hypothesis is presently under investigation.
The pathogenesis of paraneoplastic MG in medullary thymomas might be different from that in cortical-type TET given the fact that abnormally expressed, cross-reacting autoantigen epitopes have not been detected in the former so far (Marx et al., 1996a; Mtiller-Hermelink et al., 1996) (Tnvn) . In a second step, these AChR and titin-specific T cells are thought to leave the thymus and become actived T cells (Ta) only outside the tumor. The etiology-triggering T-cell activation is unknown (Vincent, 1994) .
of MG-associated medullary thymoma (Nenninger et al., 1996) (Marx et al., 1996b) . Detection of titin and AChR epitopes in neurofilaments was achieved using recombinantly produced neurofilament fragment NF-M aa459-737 for Western blotting applying mAb 155 and the anti-titin mAb 63/15 .
Flow Cytometry
Three-color FACS analyses on a Becton-Dickinson FACS scan was performed as described previously (Nenninger et al., 1996) .
T-Cell Proliferation Assay
MATERIALS AND METHODS

Patients and Tissues
The clinical data of patients with paraneoplastic MG and the histological findings of their TET summarized in this paper have been published previously Mtiller-Hermelink et al., 1996; Marx et al., 1996a; Nenninger et al., 1996) . Normal thymuses were obtained during thoracic surgery. Tumors were classified according to Mtiller-Hermelink and co-workers (1996, 1997) . The diagnosis of generalized MG was based on clinical findings, electrophysiological investigations, and anti-AChR serum titers that were >1 nmol/1.
The T-cell proliferation assay using density-gradientenriched cell suspensions from minced thymoma or nonneoplastic thymic tissue or peripheral blood mononuclear cells were performed as described by Melms et al. (1992) . Since density-gradient-enriched thymoma-cell suspensions (and to a smaller extent thymus-cell suspensions) were found to exhibit a suboptimal antigen-presenting capacity, 5 104 responder cells from thymoma and thymus samples were supplemented with 105 irradiated (50 Gy) peripheral blood mononuclear cells for improved antigen presentation (unpublished). Antigens used in proliferation assays were supplied at optimal concentrations (peptides, 10 /g/ml; recombinant protein fragments, 1 /zg/ml).
Immunohistochemistry
The application of the anti-AChR monoclonal antibody (mAb) 155 and of the various anti-neurofilament and anti-titin mAb in a three-step immunoperoxidase staining has been described previously (Kirchner et al., 1988b; Marx et al., 1996b) . and the BIOMED Project of the European Community.
